Clinical features and risk factors of postsurgical gout
- PMID: 17998214
- DOI: 10.1136/ard.2007.078683
Clinical features and risk factors of postsurgical gout
Abstract
Objectives: To investigate the clinical characteristics and risk factors of gout attacks that develop during the postsurgical period.
Methods: We enrolled 67 patients with gout who developed postsurgical gout and 67 controls who had histories of gout but did not develop gout attacks after surgery. Features of the postsurgical gout attacks were analysed and compared to those of presurgical gout attacks suffered by patients and controls. Demographics, medical backgrounds, laboratory data and surgical factors were compared between patients and controls in order to establish risk factors associated with postsurgical gout.
Results: The mean (SD) time interval to develop postsurgical gout was 4.2 (3.1) days. The attacks tended to involve lower extremity joints (65/67, 97.0%), usually the first metatarsophalangeal joint (42/67, 62.7%), and to affect more than one joint (34/67, 50.7%). The number of attacked joints was positively correlated with the total number of previously involved joints (r = 0.281, p = 0.026). The site of attacks had a preference for the previously affected sites. A history of cancer surgery (p = 0.002), elevated presurgical serum urate levels (>/=9 mg/dl; p = 0.002) and failure to administer colchicine prophylaxis (p = 0.008) were found to be risk factors for postsurgical gout.
Conclusions: Postsurgical gout tends to develop within 8 days after surgery. The site and number of involved joints reflect the features of gout attacks the patient suffered before surgery. Adequate presurgical control of serum uric acid levels and/or prophylactic administration of colchicine will help prevent gout attacks during the postsurgical period.
Similar articles
-
Clinical characteristics and risk factors for gout flare during the postsurgical period.Adv Rheumatol. 2019 Jul 25;59(1):31. doi: 10.1186/s42358-019-0075-7. Adv Rheumatol. 2019. PMID: 31345250
-
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?J Rheumatol. 2001 Mar;28(3):577-80. J Rheumatol. 2001. PMID: 11296962 Clinical Trial.
-
Endovascular Interventional Procedure is a Significant Risk Factor of Postsurgical Gout: A Retrospective Cohort Study.Rheumatol Ther. 2024 Feb;11(1):51-60. doi: 10.1007/s40744-023-00617-2. Epub 2023 Nov 6. Rheumatol Ther. 2024. PMID: 37930614 Free PMC article.
-
Diagnosis and treatment of gout in primary care.Practitioner. 2011 Dec;255(1746):17-20, 2-3. Practitioner. 2011. PMID: 22272526 Review.
-
The pathogenesis of gout.Cleve Clin J Med. 2008 Jul;75 Suppl 5:S2-4. doi: 10.3949/ccjm.75.suppl_5.s2. Cleve Clin J Med. 2008. PMID: 18822468 Review.
Cited by
-
Risk Factors for Postsurgical Gout Flares after Thoracolumbar Spine Surgeries.J Clin Med. 2022 Jun 28;11(13):3749. doi: 10.3390/jcm11133749. J Clin Med. 2022. PMID: 35807031 Free PMC article.
-
Combined Use of Febuxostat and Colchicine Does Not Increase Acute Hepatotoxicity in Patients with Gout: A Retrospective Study.J Clin Med. 2020 May 15;9(5):1488. doi: 10.3390/jcm9051488. J Clin Med. 2020. PMID: 32429082 Free PMC article.
-
Inpatient gout: a review.Curr Rheumatol Rep. 2014 Nov;16(11):458. doi: 10.1007/s11926-014-0458-z. Curr Rheumatol Rep. 2014. PMID: 25304216 Review. No abstract available.
-
One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.Arthritis Res Ther. 2022 Apr 20;24(1):88. doi: 10.1186/s13075-022-02772-3. Arthritis Res Ther. 2022. PMID: 35443675 Free PMC article.
-
Disease-Triggered Drug Release Effectively Prevents Acute Inflammatory Flare-Ups, Achieving Reduced Dosing.Small. 2018 Aug;14(32):e1800703. doi: 10.1002/smll.201800703. Epub 2018 Jul 15. Small. 2018. PMID: 30009516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical